US Stock MarketDetailed Quotes
IGC IGC Pharma
- 0.4051
- -0.0210-4.92%
Close Jul 5 16:00 ET
30.64MMarket Cap-1841P/E (TTM)
0.4269High0.4010Low163.48KVolume0.4269Open0.4260Pre Close67.28KTurnover0.24%Turnover RatioLossP/E (Static)75.64MShares0.909952wk High4.18P/B28.13MFloat Cap0.250152wk Low--Dividend TTM69.45MShs Float71.1000Historical High--Div YieldTTM6.08%Amplitude0.0001Historical Low0.4110Avg Price1Lot Size
IGC Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 26.22%-5.2M | 65.33%-526K | 3.70%-1.59M | 4.03%-1.62M | 33.15%-1.47M | 5.56%-7.05M | -71.03%-1.52M | 31.96%-1.65M | 26.76%-1.69M | -18.64%-2.2M |
| Net income from continuing operations | -12.98%-13M | 28.41%-2.89M | -148.51%-5.59M | -0.37%-2.45M | 25.49%-2.08M | 23.38%-11.51M | 38.03%-4.03M | 5.54%-2.25M | 43.78%-2.44M | -55.76%-2.79M |
| Operating gains losses | -212.82%-44K | ---- | ---- | ---- | ---- | --39K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -3.04%637K | 7.19%164K | -6.98%160K | -7.06%158K | -4.32%155K | 0.92%657K | -7.27%153K | 3.61%172K | 4.29%170K | 3.18%162K |
| Other non cash items | ---- | ---- | ---- | ---- | -177.94%-53K | ---- | ---- | ---- | ---- | 115.81%68K |
| Change In working capital | 138.54%1.89M | 1.39%1.67M | -6.12%-52K | 926.67%124K | 118.66%148K | -68.69%794K | -52.57%1.65M | 93.29%-49K | 94.30%-15K | -1,752.08%-793K |
| -Change in receivables | -600.00%-25K | -129.55%-39K | 170.97%44K | 309.52%88K | -413.04%-118K | -90.00%5K | 238.46%132K | -148.00%-62K | -282.61%-42K | -276.92%-23K |
| -Change in inventory | 12.37%1.01M | -7.38%1.02M | -1,250.00%-23K | 103.91%5K | 113.51%10K | -53.52%897K | -41.62%1.1M | -97.18%2K | -481.82%-128K | -3,800.00%-74K |
| -Change in prepaid assets | -74.62%150K | 70.77%-19K | -23.77%93K | -90.67%43K | -54.79%33K | 9.24%591K | -108.94%-65K | 438.89%122K | 399.35%461K | 1,725.00%73K |
| -Change in payables and accrued expense | 181.63%440K | -26.05%406K | -486.21%-170K | 89.53%-29K | 129.80%233K | -243.73%-539K | -52.71%549K | 96.06%-29K | -194.68%-277K | -1,877.27%-782K |
| -Change in other current assets | 1,807.69%444K | 1,317.86%341K | 172.92%35K | 1,150.00%50K | -60.87%18K | 91.22%-26K | 90.41%-28K | -284.62%-48K | -69.23%4K | 206.98%46K |
| -Change in other current liabilities | 8.21%-123K | 8.82%-31K | 8.82%-31K | 0.00%-33K | 15.15%-28K | -109.38%-134K | -3.03%-34K | -13.33%-34K | -13.79%-33K | -217.86%-33K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 26.22%-5.2M | 65.33%-526K | 3.70%-1.59M | 4.03%-1.62M | 33.15%-1.47M | 5.56%-7.05M | -71.03%-1.52M | 31.96%-1.65M | 26.76%-1.69M | -18.64%-2.2M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -34.89%-317K | -33.47%-323K | -258.82%-61K | -60.44%72K | 96.84%-5K | 68.33%-235K | 56.24%-242K | 65.31%-17K | 504.44%182K | -66.32%-158K |
| Net PPE purchase and sale | -141.23%-94K | -18.18%-13K | -78.95%-68K | -108.91%-36K | 118.11%23K | 210.14%228K | 80.00%-11K | -40.74%-38K | 1,362.50%404K | -36.56%-127K |
| Net intangibles purchase and sale | -22.01%-377K | -87.88%-310K | 77.38%-19K | 31.03%-20K | 9.68%-28K | 42.24%-309K | 66.87%-165K | -281.82%-84K | -123.08%-29K | -1,450.00%-31K |
| Net investment purchase and sale | 200.00%154K | --0 | -75.24%26K | ---- | ---- | ---154K | ---66K | --105K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -34.89%-317K | -33.47%-323K | -258.82%-61K | -60.44%72K | 96.84%-5K | 68.33%-235K | 56.24%-242K | 65.31%-17K | 504.44%182K | -66.32%-158K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,424.00%3.52M | 66,800.00%667K | -1K | 2,702.94%2.86M | 0.00%-1K | -97.59%100K | 0.00%-1K | 0 | -97.02%102K | -100.14%-1K |
| Net issuance payments of debt | 0.00%-3K | --0 | ---1K | 0.00%-1K | 0.00%-1K | 0.00%-3K | 0.00%-1K | --0 | 0.00%-1K | ---1K |
| Net common stock issuance | 3,324.27%3.53M | --667K | --0 | 2,676.70%2.86M | --0 | -97.52%103K | --0 | --0 | -96.99%103K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,424.00%3.52M | 66,800.00%667K | ---1K | 2,702.94%2.86M | 0.00%-1K | -97.59%100K | 0.00%-1K | --0 | -97.02%102K | -100.14%-1K |
| Net cash flow | ||||||||||
| Beginning cash position | -69.45%3.2M | -72.13%1.38M | -54.31%3.03M | -78.60%1.72M | -69.45%3.2M | -28.10%10.46M | -58.59%4.95M | -54.00%6.62M | -39.54%8.05M | -28.10%10.46M |
| Current changes in cash | 72.26%-1.99M | 89.66%-182K | 0.96%-1.65M | 193.65%1.31M | 37.41%-1.47M | -76.81%-7.18M | -22.14%-1.76M | 32.65%-1.67M | -230.91%-1.4M | -93.03%-2.36M |
| Effect of exchange rate changes | 92.68%-6K | -81.82%2K | 107.69%1K | 64.29%-10K | 101.92%1K | -215.38%-82K | 127.50%11K | -192.86%-13K | -411.11%-28K | -477.78%-52K |
| End cash Position | -62.52%1.2M | -62.52%1.2M | -72.13%1.38M | -54.31%3.03M | -78.60%1.72M | -69.45%3.2M | -69.45%3.2M | -58.59%4.95M | -54.00%6.62M | -39.54%8.05M |
| Free cash flow | 25.46%-5.71M | 49.56%-851K | 17.82%-1.67M | -5.35%-1.67M | 35.60%-1.52M | 6.89%-7.67M | -14.84%-1.69M | 17.56%-2.04M | 32.34%-1.59M | -20.97%-2.35M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg